Welcome to our dedicated page for Marsh & Mclennan SEC filings (Ticker: MRSH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Marsh (NYSE: MRSH) SEC filings page on Stock Titan is designed to help investors and analysts review the company’s regulatory disclosures in a structured way. While recent SEC filings are not listed in the available data, this page is where users can access Marsh’s future submissions to the US Securities and Exchange Commission once they are posted to EDGAR.
For a company that describes itself as a global leader in risk, reinsurance and capital, people and investments, and management consulting, key filings such as annual reports on Form 10-K and quarterly reports on Form 10-Q can provide important detail on business segments, risk factors, and financial performance. Current reports on Form 8-K may highlight material events, including dividend declarations or other board decisions affecting Marsh’s common stock.
When available, proxy statements and related filings can offer additional information on governance and executive matters, while Form 4 filings can be used to track transactions by directors and certain officers in Marsh’s equity.
Stock Titan enhances these documents with AI-powered summaries that explain the main points of lengthy filings in accessible language. Users can quickly see what has changed from one period to the next, identify notable disclosures, and then drill into the full text for deeper analysis. Real-time updates from EDGAR ensure that new Marsh filings appear promptly, while AI-generated insights help reduce the time required to interpret complex regulatory documents.
Marsh & McLennan Companies Chief Financial Officer receives new equity awards. On February 24, 2026, Mark C. McGivney was granted stock options for 44,743 shares at no cost and 17,961 restricted stock units, both held directly.
The options were granted on February 24, 2026 and vest in four equal annual installments on February 24 of 2027, 2028, 2029 and 2030. Both the options and restricted stock units convert into Marsh & McLennan common stock on a 1-for-1 basis. The restricted stock units relate to performance stock units originally granted on February 23, 2023 for the 2023–2025 performance period, with the performance factor determined on February 24, 2026.
Marsh & McLennan Companies reported that SVP and Chief Information Officer Paul Beswick acquired equity awards on February 24, 2026. He received 22,372 stock options that vest in four equal annual installments on February 24 of 2027, 2028, 2029 and 2030.
Beswick also acquired 6,970 restricted stock units tied to performance stock units originally granted on February 23, 2023 for the 2023–2025 performance period. Both the options and units convert into common stock on a 1‑for‑1 basis.
Marsh & McLennan Companies senior vice president and general counsel Katherine Brennan reported equity awards on common stock. She received stock options for 22,372 shares, which were granted on February 24, 2026 and vest in four equal annual installments on February 24 of 2027, 2028, 2029 and 2030.
She was also granted 6,970 restricted stock units that convert into common stock on a 1-for-1 basis. These RSUs relate to performance stock units originally granted on February 23, 2023 for the 2023–2025 performance period, with the performance factor determined on February 24, 2026.
Marsh & McLennan Companies reported an equity award for SVP and Chief People Officer Carmen Fernandez. She acquired stock options for 18,643 shares at no cost, vesting in four equal annual installments from February 24, 2027 through February 24, 2030. She also acquired 6,970 restricted stock units that convert into common stock on a 1-for-1 basis and relate to performance stock units originally granted for the 2023–2025 performance period, with the performance factor determined on February 24, 2026.
Marsh & McLennan Companies Chief Marketing Officer John Jude Jones received new equity awards. On February 24, 2026 he was granted 15,536 stock options, which vest in four equal annual installments on February 24 of 2027, 2028, 2029 and 2030.
He also acquired 4,826 restricted stock units tied to performance stock units originally granted on February 23, 2023 for the 2023–2025 performance period. Both instruments convert into Marsh & McLennan common stock on a 1‑for‑1 basis.
MARSH & MCLENNAN COMPANIES reported that Dean Michael Klisura, President & CEO of Guy Carpenter, received new equity awards. He was granted 24,858 stock options that were awarded on February 24, 2026 and vest in four equal annual installments on February 24 of 2027, 2028, 2029 and 2030. The options convert into common stock on a 1-for-1 basis.
He also acquired 9,383 restricted stock units tied to performance stock units originally granted on February 23, 2023 for the 2023–2025 performance period, with the performance factor determined on February 24, 2026. Both holdings are reported as directly owned.
Marsh & McLennan Companies President and CEO John Q. Doyle reported two equity awards. He acquired 217,501 stock options on February 24, 2026 at a grant price of $0.00 per option. These options vest in four equal annual installments on February 24 of 2027, 2028, 2029 and 2030.
He also acquired 59,510 restricted stock units on February 24, 2026. These RSUs relate to performance stock units originally granted on February 23, 2023 for the 2023–2025 performance period, with the performance factor determined on February 24, 2026. Both instruments convert into common stock on a 1-for-1 basis.
Marsh & McLennan Companies executive equity awards: South Martin, President & CEO of Marsh Risk, received stock options for 39,772 shares and 14,476 restricted stock units on February 24, 2026. The options were granted at a price of $0.00 per share.
The options vest in four equal annual installments on February 24 of 2027, 2028, 2029 and 2030 and convert into common stock on a 1-for-1 basis. The restricted stock units relate to performance stock units granted on February 23, 2023 for the 2023–2025 performance period, with the performance factor determined on February 24, 2026.
Marsh & McLennan Companies executive Nicholas Mark Studer reported equity awards rather than open‑market trades. He received stock options covering 21,129 shares of Marsh & McLennan common stock at an exercise price of $0.0000 per share. These options were granted on February 24, 2026 and vest in four equal annual installments on February 24 of 2027, 2028, 2029 and 2030.
He was also granted 8,044 restricted stock units tied to performance stock units originally granted on February 23, 2023 for the 2023–2025 performance period. The performance factor for these units was determined on February 24, 2026, and both the options and units convert into Marsh & McLennan common stock on a 1‑for‑1 basis.
Marsh & McLennan Companies Vice President and Controller Stacy Mills reported equity awards that increase her direct incentive stake in the company. On February 24, 2026, she was granted stock options for 3,574 shares at a price of $0.00 per share.
These options vest in four equal annual installments on February 24 of 2027, 2028, 2029 and 2030 and convert into common stock on a 1-for-1 basis. On the same date, she also acquired restricted stock units of 1,342 and 1,625 shares under prior and new awards, with the earlier grant tied to 2023–2025 performance and the newer grant vesting in three equal installments on February 28 of 2027, 2028 and 2029.